Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-27

Clinical Trial Update: Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating panobinostat with fluorouracil followed by leucovorin calcium in patients with Stage IV colorectal cancer who did not respond …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Leucovorin calcium (calcium folinate)
  • Panobinostat (Panobinostat)

Snippet

Sponsor: University of Southern California | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Status: TERMINATED